#BEGIN_DRUGCARD DB04637

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
4286-55-9

# ChEBI_ID:
Not Available

# Chemical_Formula:
C6H13BrO

# Chemical_IUPAC_Name:
6-bromohexan-1-ol

# Chemical_Structure:
Not Available

# Creation_Date:
2007-09-11 11:49:06 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
6-Bromo-1-hexanol

# HET_ID:
BHL

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H13BrO/c7-5-3-1-2-4-6-8/h8H,1-6H2

# InChI_Key:
InChIKey=FCMCSZXRVWDVAW-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4637

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
181.071

# Molecular_Weight_Mono:
180.014977685

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.35

# Predicted_LogS:
-2.2

# Predicted_Water_Solubility:
1.14e+00 g/l

# Primary_Accession_No:
DB04637

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
77970

# PubChem_Substance_ID:
46507239

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OCCCCCCBr

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:32 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M90050

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
mmoX

# Drug_Target_1_Gene_Sequence:
>1584 bp
ATGGCACTTAGCACCGCAACCAAGGCCGCGACGGACGCGCTGGCTGCCAATCGGGCACCC
ACCAGCGTGAATGCACAGGAAGTGCACCGTTGGCTCCAGAGCTTCAACTGGGATTTCAAG
AACAACCGGACCAAGTACGCCACCAAGTACAAGATGGCGAACGAGACCAAGGAACAGTTC
AAGCTGATCGCCAAGGAATATGCGCGCATGGAGGCAGTCAAGGACGAAAGGCAGTTCGGT
AGCCTGCAGGATGCGCTGACCCGCCTCAACGCCGGTGTTCGCGTTCATCCGAAGTGGAAC
GAGACCATGAAAGTGGTTTCGAACTTCCTGGAAGTGGGCGAATACAACGCCATCGCCGCT
ACCGGGATGCTGTGGGATTCCGCCCAGGCGGCGGAACAGAAGAACGGCTATCTGGCCCAG
GTGTTGGATGAAATCCGCCACACCCACCAGTGTGCCTACGTCAACTACTACTTCGCGAAG
AACGGCCAGGACCCGGCCGGTCACAACGATGCTCGCCGCACCCGTACCATCGGTCCGCTG
TGGAAGGGCATGAAGCGCGTGTTTTCCGACGGCTTCATTTCCGGCGACGCCGTGGAATGC
TCCCTCAACCTGCAGCTGGTGGGTGAGGCCTGCTTCACCAATCCGCTGATCGTCGCAGTG
ACCGAATGGGCTGCCGCCAACGGCGATGAAATCACCCCGACGGTGTTCCTGTCGATCGAG
ACCGACGAACTGCGCCACATGGCCAACGGTTACCAGACCGTCGTTTCCATCGCCAACGAT
CCGGCTTCCGCCAAGTATCTCAACACGGACCTGAACAACGCCTTCTGGACCCAGCAGAAG
TACTTCACGCCGGTGTTGGGCATGCTGTTCGAGTATGGCTCCAAGTTCAAGGTCGAGCCG
TGGGTCAAGACGTGGGACCGCTGGGTGTACGAGGACTGGGGCGGCATCTGGATCGGCCGT
CTGGGCAAGTACGGGGTGGAGTCGCCGCGCAGCCTCAAGGACGCCAAGCAGGACGCTTAC
TGGGCTCACCACGACCTGTATCTGCTGGCTTATGCGCTGTGGCCGACCGGCTTCTTCCGT
CTGGCGCTGCCGGATCAGGAAGAAATGGAGTGGTTCGAGGCCAACTACCCCGGCTGGTAC
GACCACTACGGCAAGATCTACGAGGAATGGCGCGCCCGCGGTTGCGAGGATCCGTCCTCG
GGCTTCATCCCGCTGATGTGGTTCATCGAAAACAACCATCCCATCTACATCGATCGCGTG
TCGCAAGTGCCGTTCTGCCCGAGCTTGGCCAAGGGCGCCAGCACCCTGCGCGTGCACGAG
TACAACGGCGAGATGCACACCTTCAGCGACCAGTGGGGCGAGCGCATGTGGCTGGCCGAG
CCGGAGCGCTACGAGTGCCAGAACATCTTCGAACAGTACGAAGGACGCGAACTGTCGGAA
GTGATCGCCGAACTGCACGGGCTGCGCAGTGATGGCAAGACCCTGATCGCCCAGCCGCAT
GTCCGTGGCGACAAGCTGTGGACGTTGGACGATATCAAACGCCTGAACTGCGTCTTCAAG
AACCCGGTGAAGGCATTCAATTGA

# Drug_Target_1_General_Function:
Involved in oxidoreductase activity

# Drug_Target_1_General_References:
11456616	Whittington DA, Lippard SJ: Crystal structures of the soluble methane monooxygenase hydroxylase from Methylococcus capsulatus (Bath) demonstrating geometrical variability at the dinuclear iron active site. J Am Chem Soc. 2001 Feb 7;123(5):827-38.
2205538	Stainthorpe AC, Lees V, Salmond GP, Dalton H, Murrell JC: The methane monooxygenase gene cluster of Methylococcus capsulatus (Bath). Gene. 1990 Jul 2;91(1):27-34.
8255292	Rosenzweig AC, Frederick CA, Lippard SJ, Nordlund P: Crystal structure of a bacterial non-haem iron hydroxylase that catalyses the biological oxidation of methane. Nature. 1993 Dec 9;366(6455):537-43.
9329079	Rosenzweig AC, Brandstetter H, Whittington DA, Nordlund P, Lippard SJ, Frederick CA: Crystal structures of the methane monooxygenase hydroxylase from Methylococcus capsulatus (Bath): implications for substrate gating and component interactions. Proteins. 1997 Oct;29(2):141-52.
9432288	Rosenzweig AC, Nordlund P, Takahara PM, Frederick CA, Lippard SJ: Geometry of the soluble methane monooxygenase catalytic diiron center in two oxidation states. Chem Biol. 1995 Sep;2(9):409-18.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5712

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
60647

# Drug_Target_1_Name:
Methane monooxygenase component A alpha chain

# Drug_Target_1_Number_of_Residues:
527

# Drug_Target_1_PDB_ID:
1XVG

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02332	Phenol_Hydrox

# Drug_Target_1_Protein_Sequence:
>Methane monooxygenase component A alpha chain
MALSTATKAATDALAANRAPTSVNAQEVHRWLQSFNWDFKNNRTKYATKYKMANETKEQF
KLIAKEYARMEAVKDERQFGSLQDALTRLNAGVRVHPKWNETMKVVSNFLEVGEYNAIAA
TGMLWDSAQAAEQKNGYLAQVLDEIRHTHQCAYVNYYFAKNGQDPAGHNDARRTRTIGPL
WKGMKRVFSDGFISGDAVECSLNLQLVGEACFTNPLIVAVTEWAAANGDEITPTVFLSIE
TDELRHMANGYQTVVSIANDPASAKYLNTDLNNAFWTQQKYFTPVLGMLFEYGSKFKVEP
WVKTWNRWVYEDWGGIWIGRLGKYGVESPRSLKDAKQDAYWAHHDLYLLAYALWPTGFFR
LALPDQEEMEWFEANYPGWYDHYGKIYEEWRARGCEDPSSGFIPLMWFIENNHPIYIDRV
SQVPFCPSLAKGASTLRVHEYNGQMHTFSDQWGERMWLAEPERYECQNIFEQYEGRELSE
VIAELHGLRSDGKTLIAQPHVRGDKLWTLDDIKRLNCVFKNPVKAFN

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Responsible for the initial oxygenation of methane to methanol in methanotrophs. It also catalyzes the monohydroxylation of a variety of unactivated alkenes, alicyclic, aromatic and heterocyclic compounds

# Drug_Target_1_SwissProt_ID:
P22869

# Drug_Target_1_SwissProt_Name:
MEMA_METCA

# Drug_Target_1_Synonyms:
EC 1.14.13.25
Methane hydroxylase

# Drug_Target_1_Theoretical_pI:
6.29

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04637
